These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31744006)

  • 1. Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
    Hegde V; Dhurandhar NV; Reddy PH
    J Alzheimers Dis; 2019; 72(s1):S71-S79. PubMed ID: 31744006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.
    Matsuzaki T; Sasaki K; Tanizaki Y; Hata J; Fujimi K; Matsui Y; Sekita A; Suzuki SO; Kanba S; Kiyohara Y; Iwaki T
    Neurology; 2010 Aug; 75(9):764-70. PubMed ID: 20739649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Insulin Resistance in the Alzheimer's Disease Progression.
    Nguyen TT; Ta QTH; Nguyen TTD; Le TT; Vo VG
    Neurochem Res; 2020 Jul; 45(7):1481-1491. PubMed ID: 32314178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does not exacerbate Alzheimer's-like phenotypes in mice.
    Murakami K; Yokoyama S; Murata N; Ozawa Y; Irie K; Shirasawa T; Shimizu T
    Biochem Biophys Res Commun; 2011 May; 409(1):34-9. PubMed ID: 21549686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
    Monacelli F; Borghi R; Cammarata S; Nencioni A; Piccini A; Tabaton M; Odetti P
    J Alzheimers Dis; 2015; 45(1):89-95. PubMed ID: 25471189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline.
    Walker JM; Harrison FE
    Nutrients; 2015 Sep; 7(9):7332-57. PubMed ID: 26340637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
    Luchsinger JA
    Eur J Pharmacol; 2008 May; 585(1):119-29. PubMed ID: 18384771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status.
    Takalo M; Haapasalo A; Martiskainen H; Kurkinen KM; Koivisto H; Miettinen P; Khandelwal VK; Kemppainen S; Kaminska D; Mäkinen P; Leinonen V; Pihlajamäki J; Soininen H; Laakso M; Tanila H; Hiltunen M
    J Nutr Biochem; 2014 Jun; 25(6):634-41. PubMed ID: 24746833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiposity, type 2 diabetes, and Alzheimer's disease.
    Luchsinger JA; Gustafson DR
    J Alzheimers Dis; 2009; 16(4):693-704. PubMed ID: 19387106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2).
    Gregory JM; Smith TJ; Slaughter JC; Mason HR; Hughey CC; Smith MS; Kandasamy B; Greeley SAW; Philipson LH; Naylor RN; Letourneau LR; Abumrad NN; Cherrington AD; Moore DJ
    Diabetes; 2019 Aug; 68(8):1565-1576. PubMed ID: 31092478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Diabetes Mellitus Easily Develops into Alzheimer's Disease via Hyperglycemia and Insulin Resistance.
    Li T; Cao HX; Ke D
    Curr Med Sci; 2021 Dec; 41(6):1165-1171. PubMed ID: 34874485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.
    Manchanayake J; Chitturi S; Nolan C; Farrell GC
    J Gastroenterol Hepatol; 2011 Mar; 26(3):510-6. PubMed ID: 21155882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 3 diabetes (Alzheimer's disease): new insight for promising therapeutic avenues.
    Candasamy M; Mohamed Elhassan SA; Kumar Bhattamisra S; Hua WY; Sern LM; Binti Busthamin NA; Mohamad Ilni NB; Shun NS; Baohong L; Ya NS; Ying NW
    Panminerva Med; 2020 Sep; 62(3):155-163. PubMed ID: 32208408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease.
    Haan MN
    Nat Clin Pract Neurol; 2006 Mar; 2(3):159-66. PubMed ID: 16932542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment.
    Craft S
    Curr Alzheimer Res; 2007 Apr; 4(2):147-52. PubMed ID: 17430239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes drugs in the fight against Alzheimer's disease.
    Boccardi V; Murasecco I; Mecocci P
    Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.